Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HY-072808 ointment in adults with atopic dermatitis
CTR20222009Phase 2Completed
- Sponsor
- Hefei Yigong Pharmaceutical
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HY-072808 in atopic dermatitis (AD), sponsored by Hefei Yigong Pharmaceutical. Started Aug 2022; status: completed.
02
Drugs
HY-072808
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20222009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222009.